US Stock MarketDetailed Quotes

OPRX OptimizeRx

Watchlist
  • 5.110
  • -0.100-1.92%
Close Nov 5 16:00 ET
  • 5.510
  • +0.400+7.83%
Pre 08:24 ET
93.62MMarket Cap-5059P/E (TTM)

OptimizeRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OptimizeRx Q3 2024 Estimates Date

Currency：USDNov 13, 2024

Estimate YoY
Revenue
25.00M
+53.06%
EPS
-0.19
-10.30%
Analyst Rating
Strong Buy

Oct 31, 2024

OptimizeRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 37.081M--
Nov 13, 20242024/Q3-- / 24.997M--
Aug 8, 20242024/Q218.812M / 20.463M--
May 14, 20242024/Q119.690M / 18.132M--
Mar 28, 20242023/Q428.369M / 26.946M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 37.081M--
Nov 13, 20242024/Q3-- / 24.997M--
Aug 8, 20242024/Q218.812M / 20.463M--
May 14, 20242024/Q119.690M / 18.132M--
Mar 28, 20242023/Q428.369M / 26.946M--

Unlock Free Earnings Estimates

OptimizeRx Earnings Reports

  • OptimizeRx | 10-Q: Q2 2024 Earnings Report

    Aug 15 16:34 ET

  • OptimizeRx | 10-Q: Q1 2024 Earnings Report

    May 15 17:08 ET

  • OptimizeRx | 10-K: FY2023 Annual Report

    Apr 15 16:45 ET

  • OptimizeRx | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 16:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data